Tianjin TEDA Biomedical Engineering Balance Sheet Health
Financial Health criteria checks 4/6
Tianjin TEDA Biomedical Engineering has a total shareholder equity of CN¥59.1M and total debt of CN¥98.7M, which brings its debt-to-equity ratio to 167.1%. Its total assets and total liabilities are CN¥310.1M and CN¥251.0M respectively.
Key information
167.1%
Debt to equity ratio
CN¥98.65m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥92.73m |
| Equity | CN¥59.05m |
| Total liabilities | CN¥251.00m |
| Total assets | CN¥310.05m |
Recent financial health updates
Is Tianjin TEDA Biomedical Engineering (HKG:8189) Weighed On By Its Debt Load?
Sep 12
Is Tianjin TEDA Biomedical Engineering (HKG:8189) A Risky Investment?
Apr 07Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?
Nov 01Tianjin TEDA Biomedical Engineering (HKG:8189) Is Making Moderate Use Of Debt
Apr 21Is Tianjin TEDA Biomedical Engineering (HKG:8189) Using Too Much Debt?
Oct 26Tianjin TEDA Biomedical Engineering (HKG:8189) Has Debt But No Earnings; Should You Worry?
Apr 06Recent updates
There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 73% Price Jump
Oct 17There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 38% Price Jump
Aug 16Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) 26% Share Price Plunge Could Signal Some Risk
May 07Is Tianjin TEDA Biomedical Engineering (HKG:8189) Weighed On By Its Debt Load?
Sep 12Investors Give Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189) Shares A 28% Hiding
Apr 17Is Tianjin TEDA Biomedical Engineering (HKG:8189) A Risky Investment?
Apr 07Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?
Nov 01Tianjin TEDA Biomedical Engineering (HKG:8189) Is Making Moderate Use Of Debt
Apr 21Is Tianjin TEDA Biomedical Engineering (HKG:8189) Using Too Much Debt?
Oct 26Tianjin TEDA Biomedical Engineering (HKG:8189) Has Debt But No Earnings; Should You Worry?
Apr 06Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?
Dec 22
Financial Position Analysis
Short Term Liabilities: 8189's short term assets (CN¥200.4M) do not cover its short term liabilities (CN¥224.2M).
Long Term Liabilities: 8189's short term assets (CN¥200.4M) exceed its long term liabilities (CN¥26.8M).
Debt to Equity History and Analysis
Debt Level: 8189's net debt to equity ratio (10%) is considered satisfactory.
Reducing Debt: 8189's debt to equity ratio has increased from 16.6% to 167.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 8189 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 8189 has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 10.5% each year.